This may include advertising from us and 3rd parties based on our understanding. A team of researchers at the University of Pennsylvania have looked at the potential to create chewing gum loaded with ACE 2, the protein that SARS-CoV- 2 attaches to attack our bodies. They believe that the oral-use medicine, called CTB-ACE 2 would block the viral load in saliva and help prevent infecting others. They believe it could lessen the severity of COVID- 19 symptoms.
According to the findings, chewing gum could reduce the viral load in saliva by up to 95 percent. They believe it could stop the virus from reaching its victims and stop transmission when infected people talk, breathe, cough or sneeze. The researchers at the University of Michigan have developed plants and chloroplasts that meet the requirements of the US Food and Drug Administration FDA. The chewing gum contains ACE 2 proteins, which are the proteins in human cells that the SARS-CoV- 2 coronaviruses grab onto to infect and spread through the human body. The experts noted in their study: Salivary glands are the main site of SARS-CoV-2 replication. CE 2 released by chewing gum is a novel approach to reducing a virus infection. Chewing gum with virus-trapping proteins is a relatively inexpensive strategy to protect patients from most oral virus infections by reducing or minimising transmission to others. To get their stunning results, the researchers compared 10 saliva samples from hospitalised patients with Covid and 10 samples from volunteers free of SARS-CoV- 2 infection. READ MORE: Russia threatens millions as it runs rampant in Irish waters: No idea what's going on'